Mike Biotech (300463.SZ) announced first-half results, with net profit of 34.257 million yuan to mother, an increase of 0.63% over the previous year

According to the Zhitong Finance App, Mike Biotech (300463.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 1,034 billion yuan, a year-on-year decrease of 3.82%. Net profit attributable to shareholders of listed companies was RMB 34.257 million, an increase of 0.63% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 32.940,800, a year-on-year decrease of 47.76%. Basic earnings per share were $0.0567.